Idiopathic inflammatory myopathies (IIM), also known as myositis, are a heterogeneous
group of autoimmune disorders with varying clinical manifestations, treatment responses and …

Objective In addition to inducing a self‐limited myopathy, statin use is associated with an
immune‐mediated necrotizing myopathy (IMNM), with autoantibodies that recognize ∼200‐kd …

Objective To develop an evidence‐based guideline on contraception, assisted reproductive
technologies ( ART ), fertility preservation with gonadotoxic therapy, use of menopausal …

Objective Myofiber necrosis without prominent inflammation is a nonspecific finding in patients
with dystrophies and toxic or immune‐mediated myopathies. However, the etiology of a …

… Christopher-Stine and Mammen have patented and licensed a test for anti–3-hydroxy-3-…
Christopher-Stine and Mammen have patented and licensed a test for anti–3-hydroxy-3-…

The idiopathic inflammatory myopathies (IIMs) affect more than 60,000 individuals in the
United States and an estimated 770,000 worldwide. 1 Although widely considered a disease …

… Christopher-Stine has received consultant fees, speaking fees, and/or honoraria (less than
$10,000 each) from Novartis, MedImmune, Questcor, Biogen Idec, and URL; has served as …

Background Cardiovascular disease is one of the major causes of death in systemic lupus
erythematosus (SLE). A study was undertaken to investigate whether treatment with statins …

Objective To develop response criteria for adult dermatomyositis (DM) and polymyositis (PM).
Methods Expert surveys, logistic regression, and conjoint analysis were used to develop …

… MAMMEN,1 DANIEL GAUDET,2 DIANE BRISSON,2 LISA CHRISTOPHER-STINE,1 THOMAS
E. … Mammen and Christopher-Stine hold a patent for an anti-HMGCR antibody assay. …